antitope.co.uk Report : Visit Site

Technical data of the antitope.co.uk

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host antitope.co.uk. Currently, hosted in Singapore and its service provider is CloudFlare Inc. .

the related websites

terrapinn.com ukspa.org.uk apsgb.co.uk babraham.co.uk reed.co.uk 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called nginx containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

skip to content investor relations careers search for: biology chemistry manufacturing about us contact us discovery antibody discovery developability assessment hybridoma sequencing immunology immunogenicity assessment cytokine screen™ custom immunology assays mhc associated peptide proteomics cell signalling analysis protein engineering ig class and isotype switching antibody reformatting affinity maturation antibody humanisation germline cdr grafting humanisation composite antibody humanisation™ humanisation by design only protein deimmunisation pegylation bespoke projects antibody production cell line development nbe cell line development biosimilar cell line development host cell switching and recloning early transfer to gmp manufacturing bioassays drug conjugate and payload characterisation binding & competition cell health assays functional assays fc binding and function assays bespoke assay development bioanalytics candidate selection biosimilarity protein and peptide identification adc characterisation analytical method development discovery antibody discovery developability assessment hybridoma sequencing immunology immunogenicity assessment cytokine screen™ custom immunology assays mhc associated peptide proteomics cell signalling analysis protein engineering ig class and isotype switching antibody reformatting affinity maturation antibody humanisation germline cdr grafting humanisation composite antibody humanisation™ humanisation by design only protein deimmunisation pegylation bespoke projects antibody production cell line development nbe cell line development biosimilar cell line development host cell switching and recloning early transfer to gmp manufacturing bioassays drug conjugate and payload characterisation binding & competition cell health assays functional assays fc binding and function assays bespoke assay development bioanalytics candidate selection biosimilarity protein and peptide identification adc characterisation analytical method development mammalian manufacturing cell line development cell banking process development manufacturing capabilities analytical development bioconjugates manufacturing bioconjugates manufacturing process development manufacturing capabilities analytical development mammalian manufacturing cell line development cell banking process development manufacturing capabilities analytical development bioconjugates manufacturing bioconjugates manufacturing process development manufacturing capabilities analytical development chemistry custom synthesis compound library synthesis hpapi & payload synthesis full time equivalent (fte) protein/bionmr services analytical capabilities bioconjugation antibody drug conjugation payloads analysis and characterisation antibody drug conjugate manufacturing peptides peptide synthesis peptide modifications peptide analytics chemistry custom synthesis compound library synthesis hpapi & payload synthesis full time equivalent (fte) protein/bionmr services analytical capabilities bioconjugation antibody drug conjugation payloads analysis and characterisation antibody drug conjugate manufacturing peptides peptide synthesis peptide modifications peptide analytics about abzena abzena’s history management board abzena inside products privacy policy terms & conditions complaints procedure cookies policy investor relations analysts investor information advisers regulatory announcements share information aim rule 26 results & presentations investor documents resources news videos posts events downloads references careers career locations vacancies apply about abzena abzena’s history management board abzena inside products privacy policy terms & conditions complaints procedure cookies policy investor relations analysts investor information advisers regulatory announcements share information aim rule 26 results & presentations investor documents resources news videos posts events downloads references careers career locations vacancies apply home page investor relations careers biology chemistry manufacturing about us contact us get in touch abzena provides technologies and complementary services across biology , chemistry and manufacturing . about us contact us abzena secures adc manufacturing services contract following the initial chemistry development, abzena subsequently developed a cell line that will now be used to produce the antibody at its gmp manufacturing facility. abzena will also conduct gmp production of the adc payload reagent and the conjugation process to create the adc for initial clinical study. read more new target for the treatment of cardiovascular fibrosis developed by enleofen bio, with support from abzena, featured in ‘nature’ article abzena will also support enleofen bio through the development of alternative strategies to block il11 signalling. abzena’s wide range of protein engineering technologies will help to translate findings from successful proof-of-concept studies in preclinical models of disease to the clinic. read more abzena and telix sign licence agreement for abzena’s prostate-specific membrane antigen antibodies under the terms of the agreement, abzena has granted telix an exclusive worldwide, royalty bearing, sub-licensable licence to its prostate-specific membrane antigen (‘psma’) antibodies in the field of radio-immunoconjugation. read more technologies and solutions abzena provides proprietary technologies and complementary solutions to organisations involved in the development of biopharmaceutical products. overview working with companies and academic groups all over the world, including most of the top biopharmaceutical companies, abzena supports the development and manufacture of better treatments for patients. view all biology abzena provides services and technologies from discovery through lead selection and optimization for biologics products. multiple antibodies which have been created using abzena’s technologies are currently being progressed through clinical development. view all chemistry abzena provides comprehensive chemistry services to pharmaceutical and biotech companies as well as governmental and academic research institutes. we have a strong background in synthetic organic chemistry and extensive experience of custom synthesis. view all manufacturing abzena’s contract development and manufacturing services are tailored to each project to ensure that the objectives are met or exceeded. experienced project teams are assigned to each project to be planned and delivered in line with the customer’s objectives. view all latest news and events abzena presents its latest research and exhibits at events all over the world. find out where we are next and our latest news below. latest news funding update: seeking to monetise royalty-bearing abzena inside products latest events webinar: designing a next generation “smart” biomanufacturing facility webinar 20 june 2018 latest news full year results: a year of transition – revenue growth driven by investment programme latest events webinar: considerations in the discovery, development and manufacture of antibody drug conjugates webinar 28 june 2018 load more resources and downloads find our latest videos, brochures and fact sheets in our resources section. download our brochure technology & solutions brochure download file antibody drug conjugates of cleavable amino-alkyl and aryl maytansinoids natural products have been used for many medicinal purposes for centuries. antibody drug conjugates (adcs)… read more manufacturing & cell line development at abzena abzena has extensive experience in cgmp and non-gmp production for recombinant proteins, antibodies and conjugates… view all resources @abzenagroup join our webinar today with @sartoriusglobal on 'designing a next generation smart biomanufacturing facility'… https://t.co/0z28ri8frr share price ... gbp | abza ... quick links home investor relations careers media contact us contact details in

URL analysis for antitope.co.uk

https://www.abzena.com/careers/
https://www.abzena.com/about/investor-information/regulatory-announcements/
https://www.abzena.com/media/events/
https://www.abzena.com/development-services/bioconjugation/analysis-and-characterisation/
https://www.abzena.com/development-services/bioconjugation/payloads/
https://www.abzena.com/contact
https://www.abzena.com/manufacturing/mammalian-manufacturing/mammalian-cell-line-development-2/
https://www.abzena.com/about/careers/vacancies/
https://www.abzena.com/manufacturing/chemistry/hpapi-payload-synthesis/
https://www.abzena.com/development-services/protein-engineering/antibody-humanization/antibody-humanizationcomposite-antibody-humanization/humanization-by-design-only/
https://www.abzena.com/#main
https://www.abzena.com/development-services/bioanalytics/
https://www.abzena.com/development-services/protein-engineering/antibody-humanization/
https://www.abzena.com/development-services/
https://www.abzena.com/development-services/bioanalytics/analytical-method-development/

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Error for "antitope.co.uk".

the WHOIS query quota for 2600:3c03:0000:0000:f03c:91ff:feae:779d has been exceeded
and will be replenished in 81 seconds

WHOIS lookup made at 14:31:06 10-Sep-2017

--
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:

Copyright Nominet UK 1996 - 2017.

You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.

  REFERRER http://www.nominet.org.uk

  REGISTRAR Nominet UK

SERVERS

  SERVER co.uk.whois-servers.net

  ARGS antitope.co.uk

  PORT 43

  TYPE domain

DISCLAIMER
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2017.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.

  REGISTERED no

DOMAIN

  NAME antitope.co.uk

NSERVER

  NS33.1AND1.CO.UK 217.160.80.150

  NS34.1AND1.CO.UK 217.160.81.150

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .